Transcat (NASDAQ:TRNS) Director Sells 504 Shares of Stock

Posted by on Aug 12th, 2026

Transcat, Inc. (NASDAQ:TRNS – Get Free Report) Director Christopher Gillette sold 504 shares of Transcat stock in a transaction on Friday, August 7th. The stock was sold at an average price of $94.23, for a total transaction of $47,491.92. Following the transaction, the director directly owned 200 shares of the company’s stock, valued at $18,846. This represents a 71.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Transcat Trading Up 2.5%

TRNS traded up $2.37 during trading on Wednesday, reaching $97.76. 170,837 shares of the stock traded hands, compared to its average volume of 152,573. The company has a quick ratio of 2.11, a current ratio of 2.49 and a debt-to-equity ratio of 0.36. The stock’s 50-day moving average is $89.75 and its 200 day moving average is $80.14. Transcat, Inc. has a 12 month low of $50.23 and a 12 month high of $98.36. The stock has a market capitalization of $915.03 million, a PE ratio of 264.22 and a beta of 0.68.

Transcat (NASDAQ:TRNS – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $92.95 million during the quarter, compared to analyst estimates of $86.55 million. Transcat had a return on equity of 5.56% and a net margin of 0.99%. Equities analysts anticipate that Transcat, Inc. will post 1.74 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Northland Securities lowered Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price target on the stock. in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Finally, Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $105.50.

Check Out Our Latest Stock Report on TRNS

Hedge Funds Weigh In On Transcat

A number of large investors have recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Transcat by 6.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after purchasing an additional 325 shares in the last quarter. Jane Street Group LLC bought a new position in shares of Transcat in the first quarter valued at $1,674,000. JPMorgan Chase & Co. lifted its stake in shares of Transcat by 88.3% in the second quarter. JPMorgan Chase & Co. now owns 8,555 shares of the scientific and technical instruments company’s stock valued at $735,000 after buying an additional 4,012 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of Transcat by 6.1% during the second quarter. Legal & General Group Plc now owns 9,551 shares of the scientific and technical instruments company’s stock valued at $821,000 after buying an additional 548 shares during the last quarter. Finally, Rhumbline Advisers grew its holdings in shares of Transcat by 23.3% during the second quarter. Rhumbline Advisers now owns 16,171 shares of the scientific and technical instruments company’s stock valued at $1,390,000 after buying an additional 3,061 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors.

About Transcat

(Get Free Report)

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.

Featured Articles

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.